Found 544 hits.
|
482. |
Maurer, M.+, Magerl, M., Aygören-Pürsün, E., Bork, K., Farkas, H., Longhurst, H., Kiani-Alikhan, S., Boullet, L., Boccon-Gibod, I., Cancian, M., Zanichelli, A., and Launay, D.: Attenuated androgen discontinuation in patients with hereditary angioedema: a commented case series. Allergy Asthma Clin. Immunol. 2022: 18; 4. IF: 2.70 |
o.482
|
495. |
Brzoza, Z.+, Badura-Brzoza, K., Maurer, M., Hawro, T., and Weller, K.: Chronic spontaneous urticaria activity, impact and control as well as their changes are strongly linked, and these links are not affected by angioedema or comorbid inducible urticaria – results from the validation of the Polish urticaria control test. World Allergy Organ J. 2022: 15; 100635. IF: 5.10 |
o.495
|
499. |
Hawro, M., Sahin, E., Steć, M., Różewicka-Czabańska, M., Raducha, E., Garanyan, L., Philipp, S., Kokolakis, G., Christou, D., Kolkhir, P., Pogorelov, D., Weller, K., Metz, M., Sabat, R., Maleszka, R., Olisova, O., Maurer, M., and Hawro, T.+: A comprehensive, tri-national, cross-sectional analysis of characteristics and impact of pruritus in psoriasis. J. Eur. Acad. Dermatol. Venereol. 2022: 36; 2064-2075. IF: 9.20 |
o.499
|
207. |
Kocatürk, E.+, Abrams, E. M., Maurer, M., Mitri, J., Oppenheimer, J., Vestergaard, C., and Zein, J.: COVID-19 and its impact on common diseases in the allergy clinics. J. Allergy Clin. Immunol. Pract. 2023: 11; 3289-3303. IF: 8.20 |
r.207
|
584. |
Staubach, P.+, Bilo, B., Fluhr, J. W., Krause, K., Kulthanan, K., Salman, A., Katelaris, C., Bernstein, J. A., Maurer, M., and Mann, C.: UCOMB-real life data: treatment strategies for chronic urticaria patients with comorbidities. J. Dermatol. Treat. 2024: 35; 2329784. IF: TBD (IF 2023: 2.90) |
o.584
|
585. |
Daci, D., Altrichter, S.+, Grillet, F., Dib, S., Mouna, A., Kumar, S. S., Terhorst-Molawi, D., Maurer, M., Günzel, D., and Scheffel, J.+: Altered sweat composition due to changes in tight junction expression of sweat glands in cholinergic urticaria patients. Int. J. Mol. Sci. 2024: 25; 4658. IF: TBD (IF 2023: 4.90) |
o.585
| 114 | Maurer, M.: Effect of omalizumab on thyroid function and autoantibody levels in patients with chronic spontaneous urticaria. Comment on: Monitoring of thyroid function in patients who exhibit IgE against thyreoperoxidase on Omalizumab. J. Allergy Clin. Immunol. 2012: 129; 270. IF: 11.00 |
|
519. |
Zhu, C.*, Fok, J., Lin, L.+, Su, H.+*, and Maurer, M.: Complete response to dupilumab in a patient with chronic spontaneous urticaria who did not tolerate omalizumab. JAAD Case Rep. 2023: 32; 109-112. IF: N/A |
o.519
|
524. |
Kolkhir, P., Laires, P. A., Salameh, P., Asero, R., Bizjak, M., Košnik, M., Dissemond, J., van Doorn, M., Hawro, T., Kasperska-Zajac, A., Zajac, M., Kocatürk, E., Peter, J., Parisi, C. A. S., Ritchie, C. A., Kulthanan, K., Tuchinda, P., Fomina, D., Kovalkova, E., Khoshkhui, M., Kouzegaran, S., Papapostolou, N., Du-Thanh, A., Kamegashira, A., Meshkova, R., Vitchuk, A., Bauer, A., Grattan, C., Staubach, P., Bouillet, L., Giménez-Arnau, A. M., Maurer, M., and Weller, K.+: The benefit of complete response to treatment in patients with chronic spontaneous urticaria – CURE results. J. Allergy Clin. Immunol. Pract. 2023: 11; 610-620. IF: 8.20 |
o.524
|
44. |
Kolkhir, P. and Maurer, M.: Chronic spontaneous urticaria and comorbidities. In: Zuberbier, T. Grattan, C., and Maurer, M., editors: Urticaria and Angioedema. 2nd ed., Switzerland: Springer, 2021 |
bc.44